Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:01 PM
Ignite Modification Date:
2025-12-24 @ 4:01 PM
NCT ID:
NCT02127866
Eligibility Criteria:
Inclusion Criteria:
* Male or female patients aged \>=18 years
* Uncontrolled asthma on medium doses of ICS+LABA with ACQ \>=1.5
* Pre-bronchodilator FEV1 ≥40% and \<80% of their predicted normal value
Exclusion Criteria:
* Pregnant or lactating women
* Diagnosis of COPD
* Patients treated for asthma exacerbations in the 4 weeks prior to study entry
* Patients who are in therapy for gastroesophageal reflux disease
* Patients who have a clinically significant cardiovascular condition
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02127866
Study Brief:
Protocol Section:
NCT02127866